Key result
In hemodialysis patients with type 2 diabetes, serum adiponectin levels positively correlated with plasma BNP and left ventricular mass index.
Cross-Sectional (n=41)
In hemodialysis patients with type 2 diabetes, increased adiponectin levels are associated with elevated BNP and left ventricular hypertrophy, suggesting modulation by chronic hypervolemia.
Answers are grounded in this paper and cite their sources.
Adiponectin-BNP-LVH link in diabetic HD patients is hypothesis-generating; leaves open biomarker or causal role pending prospective data.
BACKGROUND: Adiponectin, an adipocyte-derived hormone, has been shown to prevent the progression of left ventricular hypertrophy (LVH). However, recent studies have demonstrated increased levels of adiponectin according to the severity of chronic heart failure. We therefore investigated the relationships between adiponectin, brain natriuretic peptide (BNP), and LVH in type 2 diabetic patients on hemodialysis. METHODS: The study population comprised 41 type 2 diabetic patients on hemodialysis. Left ventricular mass index (LVMI) and criteria for LVH were determined on the basis of echocardiographic findings. Serum adiponectin and plasma BNP levels were assayed with a commercially available kit. RESULTS: Serum adiponectin levels significantly correlated with BMI (r = -0.49, p < 0.01), HDL-C (r = 0.36, p < 0.05) and TG (r = -0.49, p < 0.01). In addition, serum adiponectin levels correlated significantly and positively with plasma BNP levels (r = 0.36, p < 0.05). This relationship remained significant after adjustment for age, gender, and BMI (r = 0.34, p < 0.05). Serum adiponectin levels as well as plasma BNP levels were significantly higher than in patients without LVH (p < 0.05; p < 0.01, respectively), accompanied by a positive correlation between these levels and LVMI (r = 0.42, p < 0.01; r = 0.32, p < 0.05, respectively). CONCLUSION: Increased levels of adiponectin were associated with elevated BNP levels and LVH in hemodialysis patients with type 2 diabetes mellitus. It is speculated that adiponectin levels may be modulated by chronic hypervolemic state in this population.
No takes yet. Share an insight, caveat, or question.
Komaba et al. (2007) conducted a cross-sectional in Type 2 diabetes mellitus on hemodialysis (n=41). Serum adiponectin levels was evaluated on Correlation between serum adiponectin levels and left ventricular mass index (LVMI) (r = 0.42, p=< 0.01). In hemodialysis patients with type 2 diabetes, serum adiponectin levels positively correlated with plasma BNP and left ventricular mass index.
Synapse has enriched 10 related papers. Consider them for comparative context: